Charles R Dean
12PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Nov 30, 2022
In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor.Johanne Blais, Charles R Dean, Guillaume Lapointe
|Oct 30, 2019
Mutations Reducing In Vitro Susceptibility to Novel LpxC Inhibitors in Pseudomonas aeruginosa and Interplay of Efflux and Nonefflux Mechanisms.Adriana K Jones, Ruth E Caughlan, Angela L Woods
|Jul 05, 2019
Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry blaNDM-1.Srijan Ranjitkar, Folkert Reck, Xiaobo Ke
|May 01, 2019
Defects in Efflux (oprM), β-Lactamase (ampC), and Lipopolysaccharide Transport (lptE) Genes Mediate Antibiotic Hypersusceptibility of Pseudomonas aeruginosa Strain Z61.Xiaoyu Shen, Nicole V Johnson, Naomi N K Kreamer
|Mar 13, 2019
IID572: A New Potentially Best-In-Class β-Lactamase Inhibitor.Folkert Reck, Alun Bermingham, Johanne Blais
|Nov 14, 2018
Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in Pseudomonas aeruginosa PAO1: Uncovering a New Role for MexMN-OprM in Efflux of β-Lactams and a Novel Regulatory Circuit (MmnRS) Controlling MexMN Expression.Srijan Ranjitkar, Adriana K Jones, Mina Mostafavi
Pageof 2
